{"id":"W1982868690","doi":"10.1158/1535-7163.targ-11-b55","title":"Abstract B55: A study of REOLYSIN in combination with gemcitabine in patients with advanced pancreatic adenocarcinoma.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Gemcitabine; Tolerability; Medicine; Internal medicine; Pancreatic cancer; Oncology; Chemotherapy; Cancer; Gastroenterology; Pharmacology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015913,0.0009170521,0.002226252,0.0006136962,0.0004907732,0.0007751069,0.0006131217,0.0009018312,0.002598512],"category_scores_gemma":[0.0007206704,0.0004994879,0.001251021,0.0005899849,0.0005813767,0.0006933751,0.0003996683,0.001855601,0.0006382375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007349363,"about_ca_system_score_gemma":0.001115076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008728818,"about_ca_topic_score_gemma":0.001687343,"domain_scores_codex":[0.9993796,0.0002948248,0.00005575577,0.0001218212,0.00005683566,0.00009114939],"domain_scores_gemma":[0.9994733,0.00008473573,0.00008494625,0.00004628554,0.00002816523,0.0002826122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7332894,0.07569813,0.01738387,0.001058575,0.002021714,0.0007613125,0.0003855062,0.001729475,0.05171769,0.0001805834,0.0009746468,0.1147991],"study_design_scores_gemma":[0.09431354,0.8747675,0.02176308,0.00003822421,0.0006986805,0.0003514889,0.00006916007,0.0006201299,0.004796496,0.00004259532,0.002510632,0.00002854402],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951925,0.002030523,0.0002546783,0.0001493564,0.00006867636,0.0009695643,0.0002475778,0.00003104932,0.001056018],"genre_scores_gemma":[0.9960537,0.001106021,0.0005799571,0.0002048398,0.0001013748,0.0005216932,0.0003958052,0.000008738116,0.001027833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002598512,"threshold_uncertainty_score":0.00869292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02064877637277746,"score_gpt":0.2769907437292261,"score_spread":0.2563419673564486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}